Indeed, it reported that in patients with macular edema resistant to anti-VEGF, a single DEX implant provided BCVA improvement and CMT reduction with an efficacy lasting 6 months and without serious adverse events in any of the included studies [86]. Here, VEGFA is linked to macular retinal edema.